Clinical Trial Update: LAM561 With RT and TMZ for Adults With Glioblastoma [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for LAM561 in combination with radiotherapy and temozolomide for adults with glioblastoma (Phase 2/Phase 3) shows the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• LAM561 (LAM561)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Laminar Pharmaceuticals | Conditions: Primary Glioblastoma, Glioblastoma Multiforme | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING